| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |